Willingness to pay for health risk reductions: Differences by type of illness (original) (raw)
The Effect of Health Status on Willingness to Pay for Morbidity and Mortality Risk Reductions
Trudy Ann Cameron
2000
View PDFchevron_right
Demand for health risk reductions: A cross-national comparison between the U.S. and Canada
J.R. Deshazo
Journal of Risk and Uncertainty, 2010
View PDFchevron_right
Demand for health risk reductions
Trudy Ann Cameron
manuscript, Department of …, 2009
View PDFchevron_right
Willingness to pay for public health policies to treat illnesses
Trudy Ann Cameron
2010
View PDFchevron_right
Comorbidities and the willingness to pay for health improvements
David Crainich
Journal of Public Economics, 2003
View PDFchevron_right
Willingness to Pay for Lung Cancer Treatment: Patient Versus General Public Values
Rungpetch C. Sakulbumrungsil
International Journal of Technology Assessment in Health Care
View PDFchevron_right
Valuation of morbidity losses: meta-analysis of willingness-to-pay and health status measures
Jui-Chen Yang
2003
View PDFchevron_right
Measuring the end-of-life premium in cancer using individual ex ante willingness to pay
Lars Hultkrantz
European Journal of Health Economics, 2017
View PDFchevron_right
Willingness to Pay for Health Protection: Inadequate Sensitivity to Probability?
James Hammitt
Journal of risk and uncertainty, 1999
View PDFchevron_right
Sensitivity of willingness to pay to the magnitude of risk reduction: a TaiwanUnited States comparison
Jin-tan Liu
Journal of Risk Research, 2000
View PDFchevron_right
Willingness to pay for improving fatality risks and asthma symptoms: Values for children and adults of all ages
Glenn Blomquist
Resource and Energy Economics, 2011
View PDFchevron_right
Willingness to pay methods in health care: a sceptical view
Richard Cookson
Health Economics, 2003
View PDFchevron_right
Risk Preferences Over Health: Empirical Estimates and Implications for Healthcare Decision-Making
Drishti Baid
SSRN Electronic Journal
View PDFchevron_right
Willingness‐to‐pay for predictive tests with no immediate treatment implications: a survey of US residents
James Hammitt
2012
View PDFchevron_right
Willingness to pay for mortality risk reductions: Does latency matter?
Ramon Ortiz
Journal of Risk and Uncertainty, 2006
View PDFchevron_right
Age, health and the willingness to pay for mortality risk reductions: A contingent valuation survey of Ontario residents
Martin Heintzelman
Journal of risk and …, 2002
View PDFchevron_right
Willingness to Pay for Health-Related Quality of Life Gains in Relation to Disease Severity and the Age of Patients
Vivian T Reckers-Droog
Value in Health, 2021
View PDFchevron_right
Individual responsibility and health-risk behaviour: A contingent valuation study from the ex ante societal perspective
Bernard Van Den Berg
Health Policy, 2011
View PDFchevron_right
Understanding the global measurement of willingness to pay in health
Jörg Mahlich
Journal of Market Access & Health Policy
View PDFchevron_right
Willingness to pay for improved respiratory and cardiovascular health: a multiple-format, stated-preference approach
Reed Johnson
Health Economics, 2000
View PDFchevron_right
Predictors of willingness to pay for health benefits: an exploratory analysis of willingness to pay for small to moderate health effects among musculoskeletal and psychosomatic patients undergoing rehabilitation in Germany
Doris Gerstner
2011
View PDFchevron_right
A generalized empirical model of demand for health risk reductions
Trudy Ann Cameron
Manuscript, Department of …, 2008
View PDFchevron_right
A Behavioral Decomposition of Willingness to Pay for Health Insurance
Aleli Kraft
SSRN Electronic Journal
View PDFchevron_right
Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone
jose luis pinto prades
The European Journal of Health Economics, 2008
View PDFchevron_right
Survey Results Show That Adults Are Willing To Pay Higher Insurance Premiums For Generous Coverage Of Specialty Drugs
John Romley
Health Affairs, 2012
View PDFchevron_right
Willingness to Pay for a Quality-Adjusted Life Year: Implications for Societal Health Care Resource Allocation
William Weissert
Medical Decision Making, 2005
View PDFchevron_right
Age, health, and the willingness to pay for mortality risk reductions: a contingent valuation survey of Shizuoka, Japan, residents
MAKOTO AKAI
Environmental Economics and Policy Studies, 2007
View PDFchevron_right
The benefits of avoiding cancer (or dying from cancer): Evidence from a four- country study
Milan Ščasný
Journal of Health Economics
View PDFchevron_right
Willingness to pay to avoid metastatic breast cancer treatment side effects: results from a conjoint analysis
Thomas Bramley
SpringerPlus, 2014
View PDFchevron_right